Active Ingredient History
Vonicog alfa, sold under the brand names Vonvendi and Veyvondi, is a medication used to control bleeding in adults with von Willebrand disease. It is a recombinant von Willebrand factor. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
von Willebrand Diseases (approved 2015)
Blood Coagulation Disorders (Phase 4)
Blood Platelet Disorders (Phase 4)
General Surgery (Phase 3)
Hematologic Diseases (Phase 4)
Hemophilia A (Phase 4)
Hemorrhage (Phase 4)
Postpartum Hemorrhage (Phase 3)
von Willebrand Diseases (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue